Bristol Myers Squibb ends partnership with Cellares, prompting the cell therapy maker to restructure
read at Endpoints ↗DealNegative
Bristol Myers Squibb announced that it is terminating its collaboration with Cellares after completing a comprehensive evaluation of the partnership.
The decision was driven by BMS’s assessment that the Cell Shuttle system and related development plans did not meet its strategic criteria.
Cellares said it will reorganize its operations in response to the termination, though it did not provide further details on the restructuring plan.
source
This writeup was produced by pharmadog from original reporting by Endpoints.
Original headline: “Bristol Myers ends deal with Cellares, cell therapy manufacturer to reorg”
read at Endpoints ↗82 words · retrieved Aug 25
comments(0)
5-min edit window · permanent after that